medigraphic.com
ISSN 0188-9796 (Print)

2002, Number 2

<< Back Next >>

Rev Endocrinol Nutr 2002; 10 (2)

Diagnostic criteria and classification of diabetes mellitus, current concepts

Mancillas ALG, Gómez PFJ, Rull RJA

Language: Spanish
References: 34
Page: 62-68
PDF size: 95.74 Kb.


ABSTRACT

This review article presents a brief historical perspective of diagnostic criteria used for diabetes mellitus. The current diagnostic recommendations from the American Diabetes Association and from the World Health Organization differs in the viewpoint about the use of oral glucose tolerance test, we analyze in a simple way the reasons for use or not the oral glucose tolerance test in the patient as an individual. We also recommend to use the oral challenge in all Mexican pregnant patients with or without any other risk factor.


REFERENCES

  1. Zárate A, Rull JA. Introducción a la endocrinología, 1ª. Ed. Francisco Méndez Cervantes Ed., México, 1977.

  2. Rull JA, en Tratado de Diabetología, Gómez Pérez FJ, Rull JA Eds, México, 1996.

  3. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.

  4. Aguilar SCA, Gómez PFJ, Rull JA. Limitations of the diagnostic criteria for type 2 diabetes and glucose intolerance. Rev Invest Clin 2000; (52) 2: 177-84.

  5. World Health Organization. Diabetes mellitus: Report of a WHO study group. Geneva: WHO. 1985. Technical Report Series 727.

  6. Alberti KGMM, Zimmet PZ. For the WHO consultation. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: Provisional report of a WHO consultation. Diabetic Medicine 1998; 15: 539-53.

  7. Solfrizzi V, Panza F, Colacicco AM, Capurso C, D’Introno A, Torres F, Baldassarre G, Capurso A. Relation of Lipoprotein( a) as coronary risk factor to type 2 diabetes mellitus

  8. and low-density lipoprotein cholesterol in patients > 65 years of age (The Italian Longitudinal Study on Aging). American Journal of Cardiology. 2002; 89(7): 825-829.

  9. Katsumori K, Wasada T, Kuroki H, Arii H, Saeki A, Aoki K, Saito S, Omori Y. Prevalence of macro and microvascular diseases in non-insulin-dependent diabetic and borderline glucose-intolerant subjects with insulin resistance syndrome. Diabetes Res Clin Pract 1995; 29(3): 195-201.

  10. Fuh MM, Jeng CY, Young MM, Sheu WH, Chen YD, Reaven GM. Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with microvascular angina. Metabolism 1993; 42(9): 1090-2.

  11. The DECODE study group, on behalf of the European diabetes epidemiology group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 1999; 42: 647-54.

  12. Gerstein HC. Is glucose a continuous risk factor for cardiovascular mortality. Diabetes Care 1999; 22: 659-60.

  13. Vaccaro et al. Risk of diabetes in the new diagnostic category of impaired fasting glucose. Diabetes Care 1999; 22: 1490-1493.

  14. Finch CM, Zimmet PZ, Alberti KG. Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med 1990; 7(7): 603-10.

  15. Gómez PFJ, Aguilar SCA, López AJC et al. Lack of agreement between the WHO category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care 1998; 21: 1886-1888.

  16. Rodriguez-Moran M, Guerrero-Romero F. Fasting plasma glucose diagnostic criterion, proposed by the American Diabetes Association, has low sensitivity for diagnoses of diabetes in Mexican population. J Diabetes Complications 2001; 15(4): 171-3.

  17. Epidemiología de la diabetes en México, en Avances en diabetes, Gómez Pérez FJ Ed. Primera Edición, 1999. pp. 38-55.

  18. Zárate A, Rull JA. Introducción a la endocrinología, 1ª. Ed. Francisco Méndez Cervantes Ed., México, 1977.

  19. Rull JA, en Tratado de Diabetología, Gómez Pérez FJ, Rull JA Eds, México, 1996.

  20. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.

  21. Aguilar SCA, Gómez PFJ, Rull JA. Limitations of the diagnostic criteria for type 2 diabetes and glucose intolerance. Rev Invest Clin 2000; (52) 2: 177-84.

  22. World Health Organization. Diabetes mellitus: Report of a WHO study group. Geneva: WHO. 1985. Technical Report Series 727.

  23. Alberti KGMM, Zimmet PZ. For the WHO consultation. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: Provisional report of a WHO consultation. Diabetic Medicine 1998; 15: 539-53.

  24. Solfrizzi V, Panza F, Colacicco AM, Capurso C, D’Introno A, Torres F, Baldassarre G, Capurso A. Relation of Lipoprotein (a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients ≥ 65 years of age (The Italian Longitudinal Study on Aging). American Journal of Cardiology. 2002; 89(7): 825-829.

  25. Katsumori K, Wasada T, Kuroki H, Arii H, Saeki A, Aoki K, Saito S, Omori Y. Prevalence of macro and microvascular diseases in non-insulin-dependent diabetic and borderline glucose-intolerant subjects with insulin resistance syndrome. Diabetes Res Clin Pract 1995; 29(3): 195-201.

  26. Fuh MM, Jeng CY, Young MM, Sheu WH, Chen YD, Reaven GM. Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with microvascular angina. Metabolism 1993; 42(9): 1090-2.

  27. The DECODE study group, on behalf of the European diabetes epidemiology group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 1999; 42: 647-54.

  28. Gerstein HC. Is glucose a continuous risk factor for cardiovascular mortality. Diabetes Care 1999; 22: 659-60.

  29. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002, 25, Supplement 1, S5-S20.

  30. Vaccaro et al. Risk of diabetes in the new diagnostic category of impaired fasting glucose. Diabetes Care 1999; 22: 1490-1493.

  31. Finch CM, Zimmet PZ, Alberti KG. Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med 1990; 7(7): 603-10.

  32. Gómez PFJ, Aguilar SCA, López AJC et al. Lack of agreement between the WHO category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care 1998; 21: 1886-1888.

  33. Rodriguez-Moran M, Guerrero-Romero F. Fasting plasma glucose diagnostic criterion, proposed by the American Diabetes Association, has low sensitivity for diagnoses of diabetes in Mexican population. J Diabetes Complications 2001; 15(4): 171-3.

  34. Epidemiología de la diabetes en México, en Avances en diabetes, Gómez Pérez FJ Ed. Primera Edición, 1999. pp. 38-55.




2020     |     www.medigraphic.com